As of Feb 21, 2025, the Mannkind stock's PE ratio is 72.0. This takes into account the latest EPS of $0.08 and stock price of $5.76.
The PE ratio of Mannkind has averaged 50.11 over the last nine years. The current P/E ratio of 72.0 is 44% higher than the historical average. Looking back at the last nine years, MNKD's PE ratio peaked in the Mar 2024 quarter at 113.25, when the price was $4.53 and the EPS was $0.04. The lowest point was in the Jun 2017 quarter, when it reached 1.02 with a price of $1.41 and an EPS of $1.38.
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
2023 | N/A | N/A | $3.64 | -$0.04 |
2022 | N/A | N/A | $5.27 | -$0.34 |
2021 | N/A | N/A | $4.37 | -$0.32 |
2020 | N/A | N/A | $3.13 | -$0.26 |
2019 | N/A | N/A | $1.29 | -$0.27 |
2018 | N/A | N/A | $1.06 | -$0.6 |
2017 | N/A | N/A | $2.32 | -$1.13 |
2016 | 2.32 | N/A | $3.18 | $1.37 |
2015 | N/A | N/A | $7.25 | -$4.54 |
2014 | N/A | N/A | $26.08 | -$2.57 |
2013 | N/A | N/A | $26 | -$3.2 |
2012 | N/A | N/A | $11.55 | -$4.7 |
2011 | N/A | N/A | $12.5 | -$6.6 |
2010 | N/A | N/A | $40.3 | -$7.5 |
2009 | N/A | N/A | $43.8 | -$10.35 |
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
Sep 2024 | 78.63 | -24.68% | $6.29 | $0.08 |
Jun 2024 | 104.4 | -7.81% | $5.22 | $0.05 |
Mar 2024 | 113.25 | N/A | $4.53 | $0.04 |
Dec 2023 | N/A | N/A | $3.64 | -$0.04 |
Sep 2023 | N/A | N/A | $4.13 | -$0.12 |
Jun 2023 | N/A | N/A | $4.07 | -$0.19 |
Mar 2023 | N/A | N/A | $4.1 | -$0.28 |
Dec 2022 | N/A | N/A | $5.27 | -$0.34 |
Sep 2022 | N/A | N/A | $3.09 | -$0.38 |
Jun 2022 | N/A | N/A | $3.81 | -$0.34 |
Mar 2022 | N/A | N/A | $3.68 | -$0.37 |
Dec 2021 | N/A | N/A | $4.37 | -$0.32 |
Sep 2021 | N/A | N/A | $4.35 | -$0.33 |
Jun 2021 | N/A | N/A | $5.45 | -$0.36 |
Mar 2021 | N/A | N/A | $3.92 | -$0.27 |
MNKD's current PE ratio is higher than the 10-year average.
MNKD's PE ratio stands lower than its peer stock LLY, but it is higher than MRK's and PFE's. Mannkind's current PE ratio of 72.0 is higher than the average of its peers, which is 36.02.
Stock name | PE ratio | Market cap |
---|---|---|
HALO Halozyme Therapeutics Inc | 16.5 | $7.11B |
MRK Merck & Co Inc | 18.68 | $226.4B |
PFE Pfizer Inc | 34.61 | $149.04B |
MNKD Mannkind Corp | 72 | $1.59B |
LLY ELI LILLY & Co | 74.29 | $828.4B |
NKTR Nektar Therapeutics | N/A | $171.95M |
The price to earnings ratio for MNKD stock is 72 as of Feb 21, 2025.
The highest quarterly PE ratio in the last nine years has been 113.25 and it was in the Mar 2024 quarter.
MNKD's price to earnings ratio is currently 44% above its 9-year historical average.
MNKD's PE ratio is high because its earnings per share (EPS) is low relative to its stock price.
The P/E ratio is obtained by dividing the latest price of a stock by its trailing twelve months EPS. As of today (Feb 21, 2025), Mannkind's share price is $5.76. The company's earnings per share for the trailing twelve months (TTM) ending Sep 2024 is $0.08. Therefore, Mannkind's PE ratio for today is 72. PE RATIO(72) = STOCK PRICE($5.76) / TTM EPS($0.08)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.